Corrigendum to “Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DRβ1*0402 tetramers” [Clin. Immunol. 122 (2007) 330–337]
Christian Veldman(Friedrich-Alexander-Universität Erlangen-Nürnberg), Michael Hertl(Universitätsklinikum Gießen und Marburg), Rüdiger Eming(Philipps University of Marburg), Sonja Wolff‐Franke(Universitätsklinikum Gießen und Marburg), Grete Sønderstrup(Stanford University), William W. Kwok(Virginia Mason Medical Center)
Cited by 0
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|586
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|373
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|370
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
|Journal of the European Academy of Dermatology and Venereology|2022|247